Bridgeway Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Buy
120,474
+2,475
+2% +$576K 0.59% 14
2025
Q4
$24.4M Sell
117,999
-5,611
-5% -$1.11M 0.51% 30
2025
Q3
$22.9M Sell
123,610
-27,472
-18% -$4.71M 0.49% 25
2025
Q2
$23.1M Buy
151,082
+18,507
+14% +$2.84M 0.55% 17
2025
Q1
$22M Sell
132,575
-18,629
-12% -$2.91M 0.55% 17
2024
Q4
$21.9M Buy
151,204
+454
+0.3% +$70.4K 0.49% 21
2024
Q3
$24.4M Sell
150,750
-4,147
-3% -$661K 0.53% 14
2024
Q2
$22.6M Sell
154,897
-21,959
-12% -$3.27M 0.53% 14
2024
Q1
$28M Buy
176,856
+35,546
+25% +$5.66M 0.57% 8
2023
Q4
$22.1M Buy
141,310
+5,660
+4% +$868K 0.48% 15
2023
Q3
$21.1M Sell
135,650
-8,737
-6% -$1.44M 0.51% 11
2023
Q2
$23.9M Buy
144,387
+92,178
+177% +$14.9M 0.57% 7
2023
Q1
$8.09M Buy
52,209
+33,611
+181% +$5.43M 0.21% 130
2022
Q4
$3.29M Sell
18,598
-11,864
-39% -$2.05M 0.09% 390
2022
Q3
$4.98M Sell
30,462
-15,150
-33% -$2.56M 0.13% 264
2022
Q2
$8.1M Sell
45,612
-11,050
-20% -$1.97M 0.19% 178
2022
Q1
$10M Sell
56,662
-4,700
-8% -$800K 0.19% 164
2021
Q4
$10.5M Sell
61,362
-1,300
-2% -$213K 0.2% 146
2021
Q3
$10.1M Buy
62,662
+1,300
+2% +$222K 0.19% 151
2021
Q2
$10.1M Hold
61,362
0.18% 157
2021
Q1
$10.1M Sell
61,362
-7,550
-11% -$1.22M 0.19% 151
2020
Q4
$10.8M Sell
68,912
-88,300
-56% -$13M 0.23% 119
2020
Q3
$23.4M Buy
157,212
+77,400
+97% +$11.5M 0.54% 36
2020
Q2
$11.2M Buy
79,812
+1,100
+1% +$160K 0.23% 113
2020
Q1
$10.3M Sell
78,712
-14,000
-15% -$1.99M 0.24% 109
2019
Q4
$13.5M Sell
92,712
-5,940
-6% -$806K 0.18% 112
2019
Q3
$12.8M Buy
98,652
+13,700
+16% +$1.8M 0.18% 118
2019
Q2
$11.8M Sell
84,952
-15,450
-15% -$2.14M 0.15% 121
2019
Q1
$14M Sell
100,402
-3,900
-4% -$522K 0.17% 113
2018
Q4
$13.5M Sell
104,302
-9,000
-8% -$1.26M 0.18% 114
2018
Q3
$15.7M Sell
113,302
-3,300
-3% -$439K 0.15% 120
2018
Q2
$14.1M Buy
116,602
+9,525
+9% +$1.19M 0.14% 132
2018
Q1
$13.7M Buy
107,077
+3,300
+3% +$446K 0.15% 130
2017
Q4
$14.5M Sell
103,777
-623,990
-86% -$86.9M 0.16% 121
2017
Q3
$94.6M Buy
727,767
+6,740
+0.9% +$893K 1.08% 3
2017
Q2
$95.4M Sell
721,027
-2,075
-0.3% -$265K 1.15% 2
2017
Q1
$90.1M Buy
723,102
+12,155
+2% +$1.45M 1.09% 2
2016
Q4
$81.9M Buy
710,947
+88,475
+14% +$10.2M 1.07% 3
2016
Q3
$73.5M Buy
622,472
+21,900
+4% +$2.66M 1.1% 2
2016
Q2
$72.8M Buy
600,572
+33,440
+6% +$3.8M 1.13% 1
2016
Q1
$61.4M Buy
567,132
+126,600
+29% +$13.1M 1.03% 1
2015
Q4
$45.3M Sell
440,532
-6,100
-1% -$613K 0.84% 6
2015
Q3
$41.7M Sell
446,632
-4,000
-0.9% -$387K 0.87% 4
2015
Q2
$43.9M Buy
450,632
+252,400
+127% +$25.3M 0.87% 4
2015
Q1
$19.9M Buy
198,232
+6,390
+3% +$650K 0.41% 53
2014
Q4
$20.1M Buy
191,842
+11,820
+7% +$1.25M 0.46% 45
2014
Q3
$19.2M Sell
180,022
-28,220
-14% -$2.93M 0.48% 41
2014
Q2
$21.8M Sell
208,242
-27,310
-12% -$2.76M 0.57% 24
2014
Q1
$23.1M Sell
235,552
-18,980
-7% -$1.76M 0.66% 14
2013
Q4
$23.3M Sell
254,532
-2,830
-1% -$261K 0.71% 13
2013
Q3
$22.3M Buy
257,362
+59,620
+30% +$5.35M 0.76% 7
2013
Q2
$17M Buy
+197,742
New +$16.8M 0.68% 29

Other funds holding JNJ

Bridgeway Capital Management's JNJ Position: Q1 2026 in Review

Bridgeway Capital Management increased its Johnson & Johnson (JNJ) stake by 2.1% in Q1 2026, buying an estimated $576K and bringing the position to 120,474 shares worth $29.4M. The position accounts for 0.59% of the portfolio, ranked #14.

Bridgeway Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $95.4M in Q2 2017. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bridgeway Capital Management held 120,474 shares of Johnson & Johnson worth $29.4M as of Q1 2026.
  • Bridgeway Capital Management bought 2,475 Johnson & Johnson shares in Q1 2026, an estimated $576K.
  • Johnson & Johnson made up 0.59% of Bridgeway Capital Management's portfolio in Q1 2026, its #14 holding.
  • Bridgeway Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Bridgeway Capital Management's Johnson & Johnson position peaked at $95.4M in Q2 2017.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.